Paper28508697
Collagen concentration on the facial skin of postmenopausal women after topical treatment with estradiol and genistein: a randomized double-blind controlled trial.
Silva LA and 8 others. Gynecol Endocrinol, 2017. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Collagen concentration on the facial skin of postmenopausal women after topical treatment with estradiol and genistein: a randomized double-blind controlled trial. Papers, record 28508697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28508697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Collagen concentration on the facial skin of postmenopausal women after topical treatment with estradiol and genistein: a randomized double-blind controlled trial.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen | Major topic |
| Estradiol | Major topic |
| Genistein | Major topic |
| Phytoestrogens | Major topic |
| Postmenopause | Major topic |
| Skin | Major topic |
| Double-Blind Method | |
| Face | |
| Female | |
| Humans | |
| Middle Aged |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01553773 | Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment | Derived from the trial | Yes |
Source ClinicalTrials.gov
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41735208 | The Anti-Aging Benefits of Phytoestrogens: Insights and Evidence. | Curr Med Chem | 2026 | https://conductscience.org/library/papers/41735208 | PubMed |
| 41562471 | A Randomized Controlled Trial of the Genistein Plus Bakuchiol and Vitamins (GEN+) Product for Male Facial Skin: Effects on Skin Appearance and Properties. | Skin Res Technol | 2026 | https://conductscience.org/library/papers/41562471 | PubMed |
| 40913411 | Skinspan: A Holistic Roadmap for Extending Skin Longevity With Evidence-Based Interventions. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/40913411 | PubMed |
| 40457982 | Therapeutic Potential of Genistein: Insights into Multifaceted Mechanisms and Perspectives for Human Wellness. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/40457982 | PubMed |
| 40329055 | Bioactives for Estrogen-Deficient Skin: Topical and Oral Supplement Clinical Studies. A Narrative Review. | Dermatol Ther (Heidelb) | 2025 | https://conductscience.org/library/papers/40329055 | PubMed |
| 40298643 | Natural Compounds with Beneficial Effects on Skin Collagen Type I and Mechanisms of Their Action. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40298643 | PubMed |
| 38474467 | ROS Scavenging Effect of Selected Isoflavones in Provoked Oxidative Stress Conditions in Human Skin Fibroblasts and Keratinocytes. | Molecules | 2024 | https://conductscience.org/library/papers/38474467 | PubMed |
| 37878883 | Biotransformed soybean cream as a new nutraceutical for skin care: collagen stimulation in vitro and ex vivo. | Braz J Med Biol Res | 2023 | https://conductscience.org/library/papers/37878883 | PubMed |
| 36835861 | Efficacy and Safety of the Genistein Nutraceutical Product Containing Vitamin E, Vitamin B3, and Ceramide on Skin Health in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | J Clin Med | 2023 | https://conductscience.org/library/papers/36835861 | PubMed |
| 36293214 | The Effects of Genistein at Different Concentrations on MCF-7 Breast Cancer Cells and BJ Dermal Fibroblasts. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36293214 | PubMed |
| 36183506 | Comparative effects of fractional radiofrequency and microneedling on the genitalia of postmenopausal women: Histological and clinical changes. | Clinics (Sao Paulo) | 2022 | https://conductscience.org/library/papers/36183506 | PubMed |
| 35369627 | Can genistein be a potential agent against skin side effects associated with the treatment of breast cancer? | Postepy Dermatol Alergol | 2022 | https://conductscience.org/library/papers/35369627 | PubMed |
| 33597039 | Characterization of the human skin resistome and identification of two microbiota cutotypes. | Microbiome | 2021 | https://conductscience.org/library/papers/33597039 | PubMed |
| 33088249 | Recent pharmacological advances on genistein in clinical trials. | EXCLI J | 2020 | https://conductscience.org/library/papers/33088249 | PubMed |
| 30997378 | Estrogen-deficient skin: The role of topical therapy. | Int J Womens Dermatol | 2019 | https://conductscience.org/library/papers/30997378 | PubMed |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| ESTRADIOL | CHEMBL135 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL135 | ChEMBL |
| GENISTEIN | CHEMBL44 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL44 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28508697
GET https://conductscience.org/api/papers/v1/28508697/authors